BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GEOVAX LABS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

GEOVAX LABS, INC.

via STRATEGIC MARKETING INNOVATIONS

3rd Quarter (July 1 - Sep 30) · 2016Posted Oct 17, 2016Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: GEOVAX LABS, INC.
Description: Biotechnology company developing vaccines
Location: Georgia · United States of America

Registrant

Firm: STRATEGIC MARKETING INNOVATIONS
Description: Federal relations firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Funding for vaccine development
LobbyistsWILLIAM MCCANN
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.